{"id":"https://openalex.org/W7225329112","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","title":"698 Interferon-\u03b3-producing exhausted T cells are critical for host memory response to melanoma","display_name":"698 Interferon-\u03b3-producing exhausted T cells are critical for host memory response to melanoma","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225329112","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0698"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0698","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A789.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A789.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159257715","display_name":"Yingtong Dou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yingtong Dou","raw_affiliation_strings":["UPMC Hillman Cancer Center, Pittsburgh, PA, USA","University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]},{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051485626","display_name":"Vaishali Aggarwal","orcid":"https://orcid.org/0000-0001-7964-3479","observed_orcids":["https://orcid.org/0000-0001-7964-3479"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaishali Aggarwal","raw_affiliation_strings":["UPMC Hillman Cancer Center, Pittsburgh, PA, USA","University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]},{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147410774","display_name":"Yangxi Sun","orcid":"https://orcid.org/0009-0007-8456-5816","observed_orcids":["https://orcid.org/0009-0007-8456-5816"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yangxi Sun","raw_affiliation_strings":["UPMC Hillman Cancer Center, Pittsburgh, PA, USA","University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]},{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160537072","display_name":"Creg Workman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Creg Workman","raw_affiliation_strings":["UPMC Hillman Cancer Center, Pittsburgh, PA, USA","University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]},{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001000053","display_name":"Dario A.A. Vignali","orcid":"https://orcid.org/0000-0002-2771-5992","observed_orcids":["https://orcid.org/0000-0002-2771-5992"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dario A A Vignali","raw_affiliation_strings":["Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA","UPMC Hillman Cancer Center, Pittsburgh, PA, USA","University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]},{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]},{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A789","last_page":"A789"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.037300001829862595,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exhausted-t-cells","display_name":"exhausted T cells","score":0.718999981880188},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8650000095367432},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.5669999718666077},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6309999823570251},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.4569999873638153},{"id":"https://openalex.org/keywords/immunotherapy-response-prediction","display_name":"immunotherapy response prediction","score":0.41499999165534973},{"id":"https://openalex.org/keywords/b16f10","display_name":"B16F10","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6265000104904175},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6043999791145325},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.541700005531311},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5400000214576721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43720000982284546},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4287000000476837},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4068000018596649},{"id":"https://openalex.org/C100660578","wikidata":"https://www.wikidata.org/wiki/Q18733","display_name":"Recall","level":2,"score":0.40059998631477356},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3991999924182892},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3968000113964081},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3813999891281128},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3160000145435333},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3084999918937683},{"id":"https://openalex.org/C3019111730","wikidata":"https://www.wikidata.org/wiki/Q159236","display_name":"Genetically engineered","level":3,"score":0.30640000104904175},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.30320000648498535},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.3019999861717224},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.29600000381469727},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.288100004196167},{"id":"https://openalex.org/C2777367678","wikidata":"https://www.wikidata.org/wiki/Q2304808","display_name":"Memory T cell","level":4,"score":0.2858999967575073},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2784000039100647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2766000032424927},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.26669999957084656},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.25760000944137573},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.25440001487731934},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0698","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A789.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0698","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0698","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A789.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225329112.pdf","grobid_xml":"https://content.openalex.org/works/W7225329112.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416446481","https://openalex.org/W4308384318","https://openalex.org/W7116282061","https://openalex.org/W1985149018","https://openalex.org/W4317434502","https://openalex.org/W2057918782","https://openalex.org/W4313368686","https://openalex.org/W4388081740","https://openalex.org/W2130848313","https://openalex.org/W1972997485"],"abstract_inverted_index":{"Background":[0],"Exhausted":[1],"T":[2,177,239,248,301,325,334],"cells":[3,97,148,249,274,335],"(T":[4],"EXs)":[5],"that":[6,181,290,318],"retain":[7],"the":[8,25,39,48,258,270,305,338,342,404,409,428],"ability":[9],"to":[10,257,269,307,310,323,337,368,386],"produce":[11],"interferon-gamma":[12],"(IFN\u03b3)":[13],"in":[14,47,65,96,167,184,216,231,263,396,401,414,425],"cancers":[15],"act":[16],"as":[17,24,364],"primary":[18,189],"drivers":[19],"of":[20,28,42,68,82,144,351,377],"anti-tumor":[21,37,63,313,349],"immunity,":[22],"serving":[23],"main":[26],"predictors":[27],"immunotherapy":[29],"success.":[30],"As":[31],"IFN\u03b3":[32,182,291,319],"exerts":[33],"both":[34,276],"pro-":[35],"and":[36,79,111,128,266,279,328,406],"functions,":[38],"specific":[40,228],"role":[41],"IFN\u03b3-expressing":[43],"TEXs":[44,61,185,234,294,321,353,381],"(IFN\u03b3+":[45],"TEXs)":[46],"tumor":[49,106,119,190,199,259,372,392],"microenvironment":[50],"(TME)":[51],"remains":[52],"unclear.":[53],"In":[54,242],"this":[55,213,362],"study,":[56],"we":[57,140],"investigated":[58],"how":[59],"IFN\u03b3+":[60,233,352],"modulate":[62],"immunity":[64],"mouse":[66],"models":[67],"melanoma.Methods":[69],"We":[70],"developed":[71],"a":[72,227,365],"novel":[73],"tamoxifen-inducible":[74],"murine":[75,356],"model":[76,179],"enabling":[77],"temporal":[78,229],"selective":[80],"deletion":[81],"Ifng":[83,378],"restricted":[84,256],"by":[85,293],"Lag3":[86],"expression":[87,379],"(Lag3iCreERT2-IfngLL-Rosa26LSLtdTomato;":[88],"TEX-Ifng\u0394)":[89,158],"with":[90,171,358,420],"tdTomato":[91],"reporter":[92],"confirming":[93],"targeting":[94],"efficiency":[95],"exhibiting":[98],"exhaustion":[99],"phenotypes.":[100],"Anti-tumor":[101],"responses":[102],"were":[103,121,130,165,255],"assessed":[104],"via":[105],"growth,":[107],"single-cell":[108],"RNA":[109],"sequencing":[110],"multiparametric":[112],"flow":[113],"cytometry.":[114],"For":[115],"memory":[116,196,214,238,324,384],"recall":[117],"experiments,":[118,245],"tissues":[120,309,340],"surgically":[122],"removed":[123],"on":[124,403,408,427],"day":[125,277,280],"15":[126,278],"post-inoculation":[127,282],"mice":[129,153,173,218,416],"rechallenged":[131],"30":[132],"days":[133],"after":[134,210,391],"resection.":[135],"To":[136],"isolate":[137],"cell-intrinsic":[138],"effects,":[139],"performed":[141,166],"competitive":[142,243],"co-transfers":[143],"tumor-antigen":[145],"(gp100)-specific":[146],"pMEL+":[147,157,252,271],"from":[149,251,304,341,380],"pMEL+-Rag1-/--Lag3iCreERT2":[150],"vs.":[151,156],"pMEL+-Rag1-/--Lag3iCreERT2-IfngLL":[152],"(pMEL+":[154],"TEX-Ifngintact":[155,272],"into":[159],"B16-gp100":[160],"implanted":[161],"hosts.":[162],"All":[163],"experiments":[164],"\u22653":[168],"independent":[169],"repeats":[170],"\u22655":[172],"per":[174],"group.Results":[175],"Our":[176],"EX-Ifng\u0394":[178],"demonstrated":[180,395],"ablation":[183],"did":[186],"not":[187],"impair":[188],"control":[191],"but":[192,411],"significantly":[193,261],"compromised":[194],"host":[195,383],"response":[197,385,390],"upon":[198],"rechallenge":[200,211,393],"(p":[201,283],"<":[202,222,284],"0.001,":[203,223],"mixed-effects":[204,224],"model).":[205],"Delaying":[206],"tamoxifen":[207,421],"administration":[208],"until":[209],"rescued":[212],"defect":[215],"TEX-Ifng\u0394":[217,253,415],"(figure":[219],"1;":[220],"p":[221],"model),":[225],"pinpointing":[226],"window":[230],"which":[232],"are":[235,329],"required":[236,297],"for":[237,298,331,360],"cell":[240,302,326],"development.":[241],"co-transfer":[244],"tumor-specific":[246,299],"CD8+":[247,300,333],"derived":[250],"donors":[254],"while":[260],"underrepresented":[262],"lymph":[264],"nodes":[265],"spleen":[267],"relative":[268],"donor":[273],"at":[275],"45":[281],"0.0001,":[285],"paired":[286],"t-test).":[287],"This":[288,344],"suggested":[289],"production":[292],"is":[295],"cell-intrinsically":[296],"egress":[303],"TME":[306],"peripheral":[308,339],"establish":[311],"systemic":[312],"immunity.Conclusions":[314],"These":[315],"findings":[316],"reveal":[317],"+":[320],"contribute":[322],"reservoir":[327],"important":[330],"tumor-antigen-specific":[332],"trafficking":[336],"TME.":[343],"work":[345],"identifies":[346],"previously":[347],"unrecognized":[348],"functions":[350],"through":[354],"unique":[355],"models,":[357],"implications":[359],"reinvigorating":[361],"population":[363],"therapeutic":[366],"strategy":[367],"improve":[369],"durable":[370],"long-term":[371],"control.Abstract":[373],"698":[374],"Figure":[375],"1Removal":[376],"impairs":[382],"secondary":[387],"tumor.":[388],"Memory":[389],"was":[394,412],"all":[397],"Ifng-sufficient":[398],"hosts":[399],"(shown":[400,424],"blue":[402],"left":[405],"green":[407],"right)":[410],"lost":[413],"only":[417],"when":[418],"treated":[419],"(TAM)":[422],"D11-13":[423],"red":[426],"left)":[429]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}